WallStreetZen

NYSE: BMY
Bristol Myers Squibb Co Earnings & Revenue

BMY past revenue growth

How has BMY's revenue growth performed historically?
Company
15.42%
Industry
18.11%
Market
42.59%
BMY's revenue has grown faster (19.74% per year) than the US Drug Manufacturers - General industry average (5.44%)
Performance
BMY's revenue has grown faster (19.74% per year) than the US market average (19.59%)
Performance
BMY's revenue growth is slowing down - its growth over the last year (15.42%) is below its 5-year compound annual rate (19.74%)
Performance

BMY earnings and revenue history

Current Revenue
$45.5B
Current Earnings
-$5.4B
Current Profit Margin
-11.9%

BMY Return on equity

Current Company
-14.5%
Current Industry
50.7%
Current Market
21.6%
BMY's Return on Equity (-14.5%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

BMY Return on assets

Current Company
-4.8%
Current Industry
8.3%
BMY is generating lower Return on Assets (-4.8%) than the US Drug Manufacturers - General industry average (7.57%)
Performance

BMY Return on capital employed

Current Company
-4.73%
Current Industry
12.5%
BMY's ability to generate Return on Capital (-4.73%) has decreased compared to 3 years ago (21.35%)
Performance

Bristol Myers Squibb Earnings & Revenue FAQ

What were BMY's earnings last quarter?

On Invalid Date, Bristol Myers Squibb (NYSE: BMY) reported Q3 2021 earnings per share (EPS) of $0.70, up 15.66% year over year. Total Bristol Myers Squibb earnings for the quarter were $1.55 billion. In the same quarter last year, Bristol Myers Squibb's earnings per share (EPS) was $0.83.

What was BMY's earnings growth in the past year?

As of Q4 2021, Bristol Myers Squibb's earnings has grown null year over year. Bristol Myers Squibb's earnings in the past year totalled -$5.41 billion.

What was BMY's revenue last quarter?

On Invalid Date, Bristol Myers Squibb (NYSE: BMY) reported Q3 2021 revenue of $11.62 billion up 10.28% year over year. In the same quarter last year, Bristol Myers Squibb's revenue was $10.54 billion.

What was BMY's revenue growth in the past year?

As of Q4 2021, Bristol Myers Squibb's revenue has grown 15.42% year over year. This is 2.69 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 18.11%. Bristol Myers Squibb's revenue in the past year totalled $45.47 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.